retatrutide nonalcoholic fatty liver disease nash trial Triple hormone receptor agonist for metabolic dysfunction-associated steatotic disease: a randomized phase 2a retatrutide nonalcoholic steatohepatitis nash trial
Pay in 4 interest-free payments of $6.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23

00159-0/asset/345dcf29-8998-4fe8-9563-36b9ad092177/main.assets/gr1_lrg.jpg)
























